[Regorafenib versus S-1 plus Bevacizumab for Metastatic Colorectal Cancer as Salvage Line-A Phase Ⅱ Study (OGSG1301)].
Kodama H, Yoshida M, Goto M, Nakamura M, Hasegawa H, IKeda A, Tokunaga Y, Tanigawa K, Terazawa T, Sakai D, Kurokawa Y, Kawakami H, Shimokawa T, Satoh T.
Kodama H, et al. Among authors: kurokawa y.
Gan To Kagaku Ryoho. 2021 Oct;48(10):1241-1246.
Gan To Kagaku Ryoho. 2021.
PMID: 34657055
Clinical Trial.
Japanese.